Mumbai, India

Nirogi Venkata Ramakrishna

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nirogi Venkata Ramakrishna. Retrieved from https://idiyas.com/inventor/nirogi-venkata-ramakrishna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nirogi Venkata Ramakrishna: Innovator in Pharmaceutical Patents

Introduction

Nirogi Venkata Ramakrishna is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. His work has garnered attention for its potential applications in medicine.

Latest Patents

Nirogi holds a patent for "Kodaistatins A, B, C and D, a process for their production and their use." This patent highlights his expertise in developing new compounds that could have important implications in therapeutic settings. He has successfully secured 1 patent in his career, showcasing his ability to innovate within the pharmaceutical industry.

Career Highlights

Nirogi is currently employed at Aventis Pharma Deutschland GmbH, where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other experts in the field and contribute to the advancement of pharmaceutical sciences.

Collaborations

Throughout his career, Nirogi has worked alongside talented colleagues, including Suresh R Nadkarni and Keshavapura Hosamane Swamy. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Nirogi Venkata Ramakrishna is a distinguished inventor whose work in pharmaceuticals has the potential to influence future medical treatments. His patent on Kodaistatins demonstrates his innovative spirit and commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…